Efficacy of second line chemotherapy following first line triplet chemotherapy in advanced colorectal cancer (ACRC)

被引：0
|
作者：
Hakoun, A. M. [1 ]
Gad, A. M. [2 ]
Alzahrani, A. [3 ]
Aljubran, A. [3 ]
Bazarbashi, S. [3 ]
机构：
[1] Alfaisal Univ, Coll Med, Res Off Dept, Riyadh, Saudi Arabia
[2] Ain Shams Univ, Fac Med, Dept Clin Oncol, Cairo, Egypt
[3] King Faisal Specialist Hosp & Res Ctr, Ctr Oncol, Riyadh, Saudi Arabia
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
194P
引用
收藏
页数：2
相关论文
共 50 条
  • [31] First-line chemotherapy in advanced ovarian cancer
    Colombo, N
    Parma, G
    Caspani, G
    Donesana, P
    Marinetti, E
    Mangioni, C
    TUMORI JOURNAL, 1999, 85 (03): : S23 - S26
  • [32] Predictive role of a pharmacogenetic profiling in patients with advanced colorectal cancer (ACRC) treated with first-line, 5-fluorouracil/oxaliplatin chemotherapy
    Graziano, F.
    Ruzzo, A. M.
    Loupakis, F.
    Canestrari, E.
    Santini, D.
    Catalano, V
    Ficarelli, R.
    Mari, D.
    Bisonni, R.
    Masi, G.
    Schiavon, G.
    Safina, V
    Maltese, P.
    Pizzagalli, F.
    Giordani, P.
    Lippe, P.
    Alessandroni, P.
    Giustini, L.
    Falcone, A.
    Tonini, G.
    Silva, R. R.
    Mattioli, R.
    Menichetti, E. T.
    Testa, E.
    Lai, V
    Magnani, M.
    ANNALS OF ONCOLOGY, 2006, 17 : XI42 - XI43
  • [33] Impact of peripheral neuropathy induced by platinum in first-line chemotherapy on second-line chemotherapy with paclitaxel for advanced gastric cancer
    Ryo Otsuka
    Satoru Iwasa
    Takako Yanai
    Hidekazu Hirano
    Hirokazu Shoji
    Yoshitaka Honma
    Natsuko Okita
    Atsuo Takashima
    Ken Kato
    Hironobu Hashimoto
    Masatoshi Sekiguchi
    Yoshinori Makino
    Narikazu Boku
    Masakazu Yamaguchi
    International Journal of Clinical Oncology, 2020, 25 : 595 - 601
  • [34] Efficacy and safety of triplet regimen capecitabine, oxaliplatin, and irinotecan (XELOXIRI) as first-line chemotherapy for advanced pancreatic cancer
    Cao, Bi-Yang
    Cao, Qi
    Ma, Xiao-Ting
    Ou, Kai
    Yang, Wen-Wei
    Zhang, Le-Tian
    Lu, Jing-Yu
    Jiang, Zhi-Chao
    Zhang, Wen
    Zhang, Jie
    Wang, Qi
    Gao, Li-Zhen
    Yang, Lin
    BMC CANCER, 2025, 25 (01)
  • [35] Network meta-analysis of the efficacy of first-line chemotherapy regimens in patients with advanced colorectal cancer
    Wu, Dong-Mei
    Wang, Yong-Jian
    Fan, Shao-Hua
    Zhuang, Juan
    Zhang, Zi-Feng
    Shan, Qun
    Han, Xin-Rui
    Wen, Xin
    Li, Meng-Qiu
    Hu, Bin
    Sun, Chun-Hui
    Bao, Ya-Xing
    Xiao, Hai-Juan
    Yang, Lin
    Lu, Jun
    Zheng, Yuan-Lin
    ONCOTARGET, 2017, 8 (59) : 100668 - 100677
  • [36] Efficacy of combination chemotherapy with docetaxel and irinotecan as first- or second-line treatment for advanced gastric cancer
    Sugiyama, K.
    Ishikawa, A.
    Watanabe, T.
    IGCC: PROCEEDINGS OF THE 8TH INTERNATIONAL GASTRIC CANCER CONGRESS, 2009, : 119 - 122
  • [37] Predictive role of a pharmacogenetic profiling in patients with advanced colorectal cancer (ACRC) treated with first-line, 5-fluorouracil/irinotecan chemotherapy
    Ruzzo, A. M.
    Catalano, V
    Bisonni, R.
    Loupakis, F.
    Canestrari, E.
    Santini, D.
    Ficarelli, R.
    Mari, D.
    Maltese, P.
    Schiavon, G.
    Pizzagalli, F.
    Masi, G.
    Safina, V
    Giordani, P.
    Lippe, P.
    Alessandroni, P.
    Giustini, L.
    Falcone, A.
    Tonini, G.
    Silva, R. R.
    Mattioli, R.
    Menichetti, E. T.
    Testa, E.
    Lai, V
    Magnani, M.
    Graziano, F.
    ANNALS OF ONCOLOGY, 2006, 17 : XI41 - XI42
  • [38] Metastatic Urothelial Tumor Progression Following First Line Chemotherapy: Prognostic Factors and Importance of Second Line Chemotherapy
    Ma'koseh, Mohammad S.
    Al-wardat, Rami A.
    Salam, Murad Y.
    Salah, Samer H.
    MIDDLE EAST JOURNAL OF CANCER, 2018, 9 (03) : 195 - 201
  • [39] Experience with Aflibercept as a second line chemotherapy in metastatic colorectal cancer
    Gonzalez-Flores, E.
    Gonzalez-Astorga, B.
    Urena M, T. Delgado
    Conde, V.
    Sanchez-Toro, C.
    Legeren Alvarez, M.
    Villaescusa, A.
    Galvez Montosa, F.
    Garcia-Garcia, J.
    ANNALS OF ONCOLOGY, 2016, 27 : 41 - 42
  • [40] Optimizing the Efficacy of First-Line Chemotherapy plus Bevacizumab in Metastatic Colorectal Cancer
    Shaotang Li
    Pan Dr Chi
    BioDrugs, 2011, 25 : 43 - 50
12345